Genprex

Monthly Archives: March 2022


Genprex to Participate in Upcoming Investor Conference in March

Investor presentation to highlight the Company’s gene therapies for cancer and diabetes

Read More

Independent Researchers Reaffirm REQORSA’s Potential in Cancer, Suggest REQORSA May Benefit Other Diseases and Infections

A new study published in Cancer Gene Therapy by independent researchers outlines REQORSA as a promising therapeutic candidate for combinational therapy in cancer

Read More